BRIEF-Viatris Announces Exclusive Licensing Agreement With Lexicon Pharmaceuticals For Sotagliflozin In All Markets Outside Of The U.S. And Europe

Reuters
17 Oct 2024

Oct 16 (Reuters) - Lexicon Pharmaceuticals Inc :

* VIATRIS ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH LEXICON PHARMACEUTICALS FOR SOTAGLIFLOZIN IN ALL MARKETS OUTSIDE OF THE U.S. AND EUROPE

* VIATRIS INC - ENTERS EXCLUSIVE LICENSING AGREEMENT WITH LEXICON FOR SOTAGLIFLOZIN

* VIATRIS INC - TO PAY $25 MILLION UPFRONT FOR SOTAGLIFLOZIN RIGHTS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10